|
m |
Line 1: |
Line 1: |
- | '''Mestranol''' is the 3-[[methyl]] [[ether]] of [[ethinylestradiol]]. It was the [[estrogen]] used in many of the [[combined oral contraceptive pill|first oral contraceptives]].
| |
| | | |
- | It is a biologically inactive [[prodrug]] of ethinylestradiol to which it is [[demethylation| demethylated]] in the liver with a conversion efficiency of 70% (50 µg of mestranol is [[pharmacokinetic| pharmacokinetically]] [[bioequivalent]] to 35 µg of ethinylestradiol).<ref name=faigle>{{cite book |author=Faigle, Johann W.; Schenkel, Lotte |editor=in Fraser, Ian S. (ed.) |year=1998 |chapter=Pharmacokinetics of estrogens and progestogens |title=Estrogens and Progestogens in Clinical Practice |pages=pp. 273-294 |location=London |publisher=Churchill Livingstone |id=ISBN 0-443-04706-5}}</ref>
| |
| | | |
- | Pubchem(6291)
| + | <table align='right' border=1> |
| + | <tr><td> |
| + | <jmol><jmolApplet> |
| + | <size>200</size> |
| + | <script>spin on;color atoms amino;</script> |
| + | <uploadedFileContents>NPH187.SDF</uploadedFileContents> |
| + | <color>black</color> |
| + | </jmolApplet> |
| + | </jmol> |
| + | </td></tr></table> |
| + | ==Description== |
| + | The 3-methyl ether of ETHINYL ESTRADIOL. It must be demethylated to be biologically active. It is used as the estrogen component of many combination ORAL CONTRACEPTIVES. |
| + | ==General Properties== |
| | | |
- | The 3-methyl ether of ETHINYL ESTRADIOL. It must be demethylated to be biologically active. It is used as the estrogen component of many combination ORAL CONTRACEPTIVES.
| + | <b>*Molecular Weight</b> |
- |
| + | |
- | '''KEGG'''(C07618,D00575)
| + | |
| | | |
- | '''Activity''' Estrogen
| + | 310.43 |
- | {| border="1;width:100%; height:200px;style=text-align:center"
| + | |
- | |+'''Physiochemical properties of Mestranol:'''
| + | |
- | |-
| + | |
- | ! style="background:brown; color:white" |Physical Property
| + | |
- | ! style="background:brown; color:white" |Value
| + | |
- | ! style="background:brown; color:white" |Units
| + | |
- | ! style="background:brown; color:white" |Temp (deg C)
| + | |
- | ! style="background:brown; color:white" |Source
| + | |
- | |-
| + | |
- | |Melting Point
| + | |
- | |150.5
| + | |
- | |deg C
| + | |
- | |
| + | |
- | |EXP
| + | |
- | |-
| + | |
- | |log P (octanol-water)
| + | |
- | |4.680
| + | |
- | |(none)
| + | |
- | |
| + | |
- | |EST
| + | |
- | |-
| + | |
- | |Atmospheric OH Rate Constant
| + | |
- | |9.04E-11
| + | |
- | |cm3/molecule-sec
| + | |
- | |25
| + | |
- | |EST
| + | |
- | |-
| + | |
- | |}
| + | |
- | {| border="1;width:100%; height:200px;style=text-align:center"
| + | |
- | |+'''Toxicity:'''
| + | |
- | |-
| + | |
- | ! style="background:brown; color:white" |Organism
| + | |
- | ! style="background:brown; color:white" |Test Type
| + | |
- | ! style="background:brown; color:white" |Route
| + | |
- | ! style="background:brown; color:white" |Reported Dose (Normalized Dose)
| + | |
- | ! style="background:brown; color:white" |Effect
| + | |
- | ! style="background:brown; color:white" |Source
| + | |
- | |-
| + | |
- | |mouse
| + | |
- | |LD50
| + | |
- | |intraperitoneal
| + | |
- | |> 3200mg/kg (3200mg/kg)
| + | |
- | |SENSE ORGANS AND SPECIAL SENSES: LACRIMATION: EYE
| + | |
| | | |
- | BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY)
| + | <b>*Molecular Formula</b> |
| | | |
- | SKIN AND APPENDAGES (SKIN): HAIR: OTHER
| + | C<sub>2</sub><sub>1</sub>H<sub>2</sub><sub>6</sub>O<sub>2</sub> |
- | |Oyo Yakuri. Pharmacometrics. Vol. 4, Pg. 217, 1970.
| + | |
- | |-
| + | |
- | |mouse
| + | |
- | |LD50
| + | |
- | |oral
| + | |
- | |> 10gm/kg (10000mg/kg)
| + | |
- | |SENSE ORGANS AND SPECIAL SENSES: PTOSIS: EYE
| + | |
| | | |
- | BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY)
| + | <b>*IUPAC NAME</b> |
| | | |
- | SKIN AND APPENDAGES (SKIN): HAIR: OTHER
| + | (8R,9S,13S,14S,17R)-17-ethynyl-3-methoxy-13-methyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-17-ol |
- | |Oyo Yakuri. Pharmacometrics. Vol. 4, Pg. 217, 1970.
| + | |
- | |-
| + | |
- | |mouse
| + | |
- | |LD50
| + | |
- | |subcutaneous
| + | |
- | |2500mg/kg (2500mg/kg)
| + | |
- | |SENSE ORGANS AND SPECIAL SENSES: LACRIMATION: EYE
| + | |
| | | |
- | SENSE ORGANS AND SPECIAL SENSES: PTOSIS: EYE
| + | <b>*Canonical Smiles</b> |
| | | |
- | SKIN AND APPENDAGES (SKIN): HAIR: OTHER
| + | CC12CCC3C(C1CCC2(C#C)O)CCC4=C3C=CC(=C4)OC |
- | |Oyo Yakuri. Pharmacometrics. Vol. 4, Pg. 217, 1970.
| + | |
- | |-
| + | |
- | |rat
| + | |
- | |LD50
| + | |
- | |intraperitoneal
| + | |
- | |> 3gm/kg (3000mg/kg)
| + | |
- | |BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY)
| + | |
| | | |
- | GASTROINTESTINAL: CHANGES IN STRUCTURE OR FUNCTION OF SALIVARY GLANDS
| + | <b>*Isomeric Smiles</b> |
| | | |
- | SKIN AND APPENDAGES (SKIN): HAIR: OTHER
| + | C[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@]2(C#C)O)CCC4=C3C=CC(=C4)OC |
- | |Oyo Yakuri. Pharmacometrics. Vol. 4, Pg. 217, 1970.
| + | |
- | |-
| + | |
- | |rat
| + | |
- | |LD50
| + | |
- | |oral
| + | |
- | |> 10gm/kg (10000mg/kg)
| + | |
- | |
| + | |
- | |Oyo Yakuri. Pharmacometrics. Vol. 4, Pg. 217, 1970.
| + | |
- | |-
| + | |
- | |rat
| + | |
- | |LD50
| + | |
- | |subcutaneous
| + | |
- | |> 5gm/kg (5000mg/kg)
| + | |
- | |BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY)
| + | |
| | | |
- | GASTROINTESTINAL: CHANGES IN STRUCTURE OR FUNCTION OF SALIVARY GLANDS
| |
| | | |
- | SKIN AND APPENDAGES (SKIN): HAIR: OTHER
| + | ==PhysioChemical Properties== |
- | |Oyo Yakuri. Pharmacometrics. Vol. 4, Pg. 217, 1970.
| + | |
- | |-
| + | |
- | |}
| + | |
- | ==References== | + | |
- | {{reflist}}
| + | |
| | | |
- | {{Sex hormones}}
| + | <b>*Melting Point</b> |
| | | |
- | [[Category:Hormonal contraception]]
| + | 150.5(EXP) |
- | [[Category:Synthetic estrogens]]
| + | |
- | [[Category:Prodrugs]]
| + | |
| | | |
- | [[de:Mestranol]]
| + | <b>*LogP</b> |
| | | |
- | {{pharma-stub}}
| + | 4.68(EST) |
| + | |
| + | <b>*Water Solubility</b> |
| + | |
| + | |
| + | |
| + | ==External Links== |
| + | *[http://pubchem.ncbi.nlm.nih.gov/summary/summary.cgi?cid=6291]Pubchem |
| + | *[http://www.genome.jp/dbget-bin/www_bget?compound+C07618]KEGG Compound |
| + | *[http://www.genome.jp/dbget-bin/www_bget?drug+D00575]KEGG Drug |
| + | *[http://www.drugbank.ca/drugs/DB01357]Drugbank |
| + | |
| + | [[Categories:Hormones]] |
The 3-methyl ether of ETHINYL ESTRADIOL. It must be demethylated to be biologically active. It is used as the estrogen component of many combination ORAL CONTRACEPTIVES.
(8R,9S,13S,14S,17R)-17-ethynyl-3-methoxy-13-methyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-17-ol